{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:17:17Z","timestamp":1760242637437,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cpm.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T17:19:26Z","timestamp":1554743966000},"page":"413-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Updates on Bioengineered Alternative Tissues"],"prefix":"10.1016","volume":"36","author":[{"given":"John","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Wynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9498","key":"10.1016\/j.cpm.2019.02.009_bib1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cpm.2019.02.009_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2337\/dc09-0651","article-title":"History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Tr\u00f8ndelag Health Study, Norway","volume":"32","author":"Iversen","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.cpm.2019.02.009_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1742-481X.2007.00392.x","article-title":"Guest editorial: are diabetes-related wounds and amputations worse than cancer?","volume":"4","author":"Armstrong","year":"2007","journal-title":"Int Wound J"},{"issue":"3","key":"10.1016\/j.cpm.2019.02.009_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc13-2176","article-title":"Burden of diabetic foot ulcers for Medicare and private insurers","volume":"37","author":"Rice","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cpm.2019.02.009_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/diacare.22.5.692","article-title":"Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis","volume":"22","author":"Margolis","year":"1999","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.cpm.2019.02.009_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.ASW.0000323532.98003.26","article-title":"A\u00a0multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds","volume":"21","author":"Winters","year":"2008","journal-title":"Adv Skin Wound Care"},{"issue":"11","key":"10.1016\/j.cpm.2019.02.009_bib7","first-page":"28","article-title":"Diabetic foot ulcers\u2014effects on quality of life, costs, and mortality and the role of standard wound care and advanced-care therapies in healing: a review","volume":"55","author":"Snyder","year":"2009","journal-title":"Ostomy Wound Manage"},{"issue":"3","key":"10.1016\/j.cpm.2019.02.009_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1742-481X.2009.00585.x","article-title":"Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study","volume":"6","author":"Reyzelman","year":"2009","journal-title":"Int Wound J"},{"issue":"6","key":"10.1016\/j.cpm.2019.02.009_bib9","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.26.6.1879","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"26","author":"Sheehan","year":"2003","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.cpm.2019.02.009_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM199909023411006","article-title":"Cutaneous wound healing","volume":"341","author":"Singer","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cpm.2019.02.009_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semvascsurg.2012.04.008","article-title":"Wound care: biofilm and its impact on the latest treatment modalities for ulcerations of the diabetic foot","volume":"25","author":"Kim","year":"2012","journal-title":"Semin Vasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.cpm.2019.02.009_bib12","first-page":"S1","article-title":"Wound bed preparation: a systematic approach to wound management","volume":"11","author":"Schultz","year":"2003","journal-title":"Wound Repair Regen"},{"issue":"8","key":"10.1016\/j.cpm.2019.02.009_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.12968\/jowc.2008.17.8.30796","article-title":"Biofilms and chronic wound inflammation","volume":"17","author":"Wolcott","year":"2008","journal-title":"J\u00a0Wound Care"},{"issue":"2","key":"10.1016\/j.cpm.2019.02.009_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1747.2000.00044.x","article-title":"Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity","volume":"115","author":"Cook","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.cpm.2019.02.009_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1067-1927.2005.00065.x","article-title":"Oxidative stress in chronic venous leg ulcers","volume":"13","author":"Wlaschek","year":"2005","journal-title":"Wound Repair Regen"},{"issue":"10","key":"10.1016\/j.cpm.2019.02.009_bib16","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1038\/jid.2008.114","article-title":"Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers","volume":"128","author":"Wall","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.cpm.2019.02.009_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1524-475X.2008.00369.x","article-title":"Human dermal fibroblast subpopulations; differential interactions with vascular endothelial cells in coculture: nonsoluble factors in the extracellular matrix influence interactions","volume":"16","author":"Sorrell","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.cpm.2019.02.009_bib18","series-title":"Surgical\u00a0reconstruction of the diabetic foot and ankle","first-page":"105","article-title":"Bioengineered alternative tissues for the surgical management of diabetic foot ulceration","author":"Steinberg","year":"2009"},{"issue":"7","key":"10.1016\/j.cpm.2019.02.009_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/10473","article-title":"Localized, direct plasmid gene delivery in\u00a0vivo: prolonged therapy results in reproducible tissue regeneration","volume":"5","author":"Bonadio","year":"1999","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.cpm.2019.02.009_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0168-3659(03)00097-X","article-title":"Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers","volume":"89","author":"Luu","year":"2003","journal-title":"J\u00a0Control Release"},{"issue":"5","key":"10.1016\/j.cpm.2019.02.009_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12332","article-title":"Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting","volume":"23","author":"Kirsner","year":"2015","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.cpm.2019.02.009_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1745-6215-14-8","article-title":"Cellular versus acellular matrix devices in treatment of diabetic foot ulcers: study protocol for a comparative efficacy randomized controlled trial","volume":"14","author":"Lev-Tov","year":"2013","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.cpm.2019.02.009_bib23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jbm.b.33141","article-title":"Properties of dehydrated human amnion\/chorion composite grafts: implications for wound repair and soft tissue regeneration","volume":"102","author":"Koob","year":"2014","journal-title":"J\u00a0Biomed Mater Res B Appl Biomater"},{"issue":"5","key":"10.1016\/j.cpm.2019.02.009_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/iwj.12097","article-title":"A\u00a0prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers","volume":"10","author":"Zelen","year":"2013","journal-title":"Int Wound J"},{"issue":"2","key":"10.1016\/j.cpm.2019.02.009_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7547\/17-039","article-title":"Use of dehydrated human amnion\/chorion membrane allografts in more than 100 patients with six major types of refractory nonhealing wounds","volume":"108","author":"Garoufalis","year":"2018","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/iwj.12843","article-title":"A\u00a0multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion\/chorion membrane (EpiFix) allograft for the treatment of venous leg ulcers","volume":"15","author":"Bianchi","year":"2018","journal-title":"Int Wound J"},{"issue":"7","key":"10.1016\/j.cpm.2019.02.009_bib27","first-page":"217","article-title":"A\u00a0single-center, retrospective study of cryopreserved umbilical cord for wound healing in patients suffering from chronic wounds of the foot and ankle","volume":"28","author":"Couture","year":"2016","journal-title":"Wounds"},{"issue":"Sup7","key":"10.1016\/j.cpm.2019.02.009_bib28","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.12968\/jowc.2016.25.7.S10","article-title":"A\u00a0single-centre, retrospective study of cryopreserved umbilical cord\/amniotic membrane tissue for the treatment of diabetic foot ulcers","volume":"25","author":"Raphael","year":"2016","journal-title":"J\u00a0Wound Care"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib29","article-title":"The effect of cryopreserved human placental tissues on biofilm formation of wound-associated pathogens","volume":"9","author":"Mao","year":"2018","journal-title":"J\u00a0Funct Biomater"},{"issue":"2","key":"10.1016\/j.cpm.2019.02.009_bib30","first-page":"129","article-title":"Exogenous hyaluronic acid and wound healing: an updated vision","volume":"54","author":"Prosdocimi","year":"2012","journal-title":"Panminerva Med"},{"issue":"3","key":"10.1016\/j.cpm.2019.02.009_bib31","first-page":"78","article-title":"Hyaluronic acid in inflammation and tissue regeneration","volume":"28","author":"Litwiniuk","year":"2016","journal-title":"Wounds"},{"key":"10.1016\/j.cpm.2019.02.009_bib32","first-page":"e17","article-title":"Use of hyaluronic acid-based biological bilaminar matrix in wound bed preparation: a case series","volume":"18","author":"Simman","year":"2018","journal-title":"Eplasty"},{"issue":"14","key":"10.1016\/j.cpm.2019.02.009_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1098\/rsif.2006.0179","article-title":"Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration","volume":"4","author":"Metcalfe","year":"2007","journal-title":"J\u00a0R Soc Interface"},{"issue":"2","key":"10.1016\/j.cpm.2019.02.009_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial","volume":"24","author":"Veves","year":"2001","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.cpm.2019.02.009_bib35","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2165\/00019053-200321160-00003","article-title":"The cost effectiveness of Apligraf treatment of diabetic foot ulcers","volume":"21","author":"Redekop","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/PRS.0b013e318254b1ea","article-title":"A\u00a0systematic review of skin substitutes for foot ulcers","volume":"130","author":"Felder","year":"2012","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.cpm.2019.02.009_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/diacare.19.4.350","article-title":"Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers","volume":"19","author":"Gentzkow","year":"1996","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.cpm.2019.02.009_bib38","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","article-title":"The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial","volume":"26","author":"Marston","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpm.2013.09.010","article-title":"Bioengineered alternative tissues","volume":"31","author":"Cook","year":"2014","journal-title":"Clin Podiatr Med Surg"},{"issue":"9","key":"10.1016\/j.cpm.2019.02.009_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.ASW.0000489991.32684.9e","article-title":"Characterization of a cryopreserved split-thickness human skin allograft\u2013TheraSkin","volume":"29","author":"Landsman","year":"2016","journal-title":"Adv Skin Wound Care"},{"issue":"3","key":"10.1016\/j.cpm.2019.02.009_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cpm.2018.02.006","article-title":"Randomized, prospective, blinded-enrollment, head-to-head venous leg ulcer healing trial comparing living, bioengineered skin graft substitute (Apligraf) with living, cryopreserved, human skin allograft (TheraSkin)","volume":"35","author":"Towler","year":"2018","journal-title":"Clin Podiatr Med Surg"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cpm.2014.09.004","article-title":"Bioengineered alternative tissues in diabetic wound healing","volume":"32","author":"Garwood","year":"2015","journal-title":"Clin Podiatr Med Surg"},{"issue":"4","key":"10.1016\/j.cpm.2019.02.009_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12434","article-title":"Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: highlights of a Cochrane systematic review","volume":"24","author":"Santema","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"3","key":"10.1016\/j.cpm.2019.02.009_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.12968\/jowc.2015.24.3.149","article-title":"Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular\/tissue-derived products","volume":"24","author":"Gilligan","year":"2015","journal-title":"J\u00a0Wound Care"},{"issue":"5","key":"10.1016\/j.cpm.2019.02.009_bib45","first-page":"111","article-title":"Living cells or collagen matrix: which is more beneficial in the treatment of diabetic foot ulcers?","volume":"20","author":"Landsman","year":"2008","journal-title":"Wounds"},{"key":"10.1016\/j.cpm.2019.02.009_bib46","first-page":"65","article-title":"Integra bilayer wound matrix application for complex lower extremity soft tissue reconstruction","volume":"24","author":"Kim","year":"2014","journal-title":"Surg Technol Int"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.jfas.2005.10.005","article-title":"Dermal regeneration template in the surgical management of diabetic foot ulcers: a series of five cases","volume":"45","author":"Silverstein","year":"2006","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"4","key":"10.1016\/j.cpm.2019.02.009_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1534734609350553","article-title":"The use of a dermal substitute (integra) to preserve maximal foot length in a diabetic foot wound with bone and tendon exposure following urgent surgical debridement for an acute infection","volume":"8","author":"Clerici","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.cpm.2019.02.009_bib49","first-page":"e1048","article-title":"Acellular dermal matrix and skin grafts: a long-lasting alternative for weightbearing zone reconstruction after degloving trauma of the foot","volume":"2","author":"Scalise","year":"2015","journal-title":"Musculoskelet Regen"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/PRS.0b013e3181f95c4b","article-title":"Functional limb salvage in the diabetic patient: the use of a collagen bilayer matrix and risk factors for amputation","volume":"127","author":"Iorio","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"10.1016\/j.cpm.2019.02.009_bib51","first-page":"306","article-title":"Management of open distal lower extremity wounds with exposed tendons using porcine urinary bladder matrix","volume":"28","author":"Geiger","year":"2016","journal-title":"Wounds"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib52","first-page":"18","article-title":"Small intestinal submucosa wound matrix and full-thickness venous ulcers: preliminary results","volume":"16","author":"Demling","year":"2004","journal-title":"Wounds"},{"issue":"5","key":"10.1016\/j.cpm.2019.02.009_bib53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jvs.2005.01.042","article-title":"Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial","volume":"41","author":"Mostow","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.cpm.2019.02.009_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1742-481X.2007.00300.x","article-title":"OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial\/venous aetiology","volume":"4","author":"Romanelli","year":"2007","journal-title":"Int Wound J"},{"issue":"Sup10","key":"10.1016\/j.cpm.2019.02.009_bib55","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.12968\/jowc.2016.25.Sup10.S8","article-title":"A\u00a0comparative analysis of skin substitutes used in the management of diabetic foot ulcers","volume":"25","author":"Martinson","year":"2016","journal-title":"J\u00a0Wound Care"},{"issue":"8","key":"10.1016\/j.cpm.2019.02.009_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.ASW.0000451891.87020.69","article-title":"The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study","volume":"27","author":"Kavros","year":"2014","journal-title":"Adv Skin Wound Care"},{"issue":"4","key":"10.1016\/j.cpm.2019.02.009_bib57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASW.0000428862.34294.d4","article-title":"Clinical outcomes following the use of ovine forestomach matrix (Endoform dermal template) to treat chronic wounds","volume":"26","author":"Liden","year":"2013","journal-title":"Adv Skin Wound Care"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842219300217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842219300217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:57:38Z","timestamp":1760209058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842219300217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0891842219300217"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2019.02.009","relation":{},"ISSN":["0891-8422"],"issn-type":[{"type":"print","value":"0891-8422"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on Bioengineered Alternative Tissues","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}